Contamination during 4 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST)

被引:16
作者
Saghir, Zaigham [1 ]
Ashraf, Haseem [2 ]
Dirksen, Asger [1 ]
Brodersen, John [3 ]
Pedersen, Jesper Holst [4 ]
机构
[1] Gentofte Univ Hosp, Dept Resp Med, DK-2900 Hellerup, Denmark
[2] Gentofte Univ Hosp, Dept Radiol, DK-2900 Hellerup, Denmark
[3] Univ Copenhagen, Fac Hlth Sci, Inst Publ Hlth, Dept Gen Practice, Copenhagen, Denmark
[4] Rigshosp, Dept Thorac Surg, DK-2100 Copenhagen, Denmark
关键词
Contamination; Lung neoplasms; Lung cancer; Mass screening; Computed tomography; Statistical power; Screening-effect; Over-diagnosis; Randomised controlled trial; Danish Lung Cancer Screening Trial (DLCST); PROJECT;
D O I
10.1016/j.lungcan.2010.06.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Contamination, defined as screening in the control arm, may dilute the statistical power of randomised screening trials. We investigated the rate of contamination in DLCST during 4 years of annual CT screening. Methods: DLCST is a randomised trial involving 4104 healthy current and ex smokers. 2052 subjects were randomised to annual low dose chest CT scans (CT group) and 2052 were given no intervention (control group). The study is performed in collaboration with the NELSON trial (Nederlands Leuvens Screening Onderzoek) and mortality data will be pooled at the end. We defined contamination as off study CT scan received for lung cancer screening purposes. Annually during the screening period, the participants were asked whether they had received a CT scan and if so the purpose. The causes were divided into the following categories: 'Off study screening for lung cancer', 'Investigation of lung symptoms', 'Investigation of incidental finding on chest radiograph', 'Participation in other scientific trial involving chest CT', and finally 'Chest CT for other reasons'. Results: Response rates were high in both groups: 86.1% (control group), 93.6% (CT group) p < 0.001. Control group.: 199 out of 7065 answers (2.8%) indicating acquisition of a chest CT during 4 years of the trial. Three answers fulfilled the definition of contamination, while 8 received chest CT due to involvement in other scientific trials. 126 reported CT scans as part of investigation for other diseases, while 10 and 52 went through investigations for abnormal chest radiograph and lung symptoms, respectively. CT group: Significantly lower number of answers (n = 134) indicated acquisition of an off study chest CT. None had received off study lung cancer screening. Three were involved in other scientific trials, while 17 and 115 went through investigation of lung symptoms and chest CT for other reasons, respectively. Conclusion: Although the frequency of off study chest CT was significantly higher in the control group, it was relatively small in both randomisation groups, and thus contamination seems to be modest and acceptable in the DLCST. Clinical Trial no.: Clinical Trials.gov Protocol Registration System (identification no. NCT00496977). (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 19 条
  • [1] ANDRIOLE GL, 2009, N ENGL J MED
  • [2] BAECKE E, 2009, LUNG CANC
  • [3] CT screening for lung cancer - Spiraling into confusion?
    Black, William C.
    Baron, John A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (09): : 995 - 997
  • [4] *DAN NAT BOARD HLT, 2009, DODS 2008, P6
  • [5] Danish National Board of Health, 2009, CANC 2008, P5
  • [6] Randomized Controlled Trials of the Efficacy of Lung Cancer Screening by Sputum Cytology Revisited A Combined Mortality Analysis From the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study
    Doria-Rose, V. Paul
    Marcus, Pamela M.
    Szabo, Eva
    Tockman, Melvyn S.
    Melamed, Myron R.
    Prorok, Philip C.
    [J]. CANCER, 2009, 115 (21) : 5007 - 5017
  • [7] LUNG-CANCER SCREENING - THE MAYO PROGRAM
    FONTANA, RS
    SANDERSON, DR
    WOOLNER, LB
    TAYLOR, WF
    MILLER, WE
    MUHM, JR
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1986, 28 (08) : 746 - 750
  • [8] Fontana RS, 2000, CANCER, V89, P2352, DOI 10.1002/1097-0142(20001201)89:11+<2352::AID-CNCR7>3.0.CO
  • [9] 2-5
  • [10] GOTZSCHE P, 2006, BRIT MED J, V332, P691